The most researched healing peptide available. A 15-amino acid fragment of a gastric juice protein that accelerates recovery across tendons, ligaments, muscle, gut lining, and brain tissue. BPC-157 upregulates growth factor receptors, modulates nitric oxide, and promotes angiogenesis — making it the cornerstone of the Wolverine Stack and the first peptide most people ever use.
BPC-157 doesn't just treat one tissue type or one pathway. It upregulates VEGF, EGF, and FGF receptors, modulates the NO system, promotes angiogenesis, and counteracts the effects of NSAIDs on the gut. This multi-pathway approach is why it works across such a wide range of injuries.
BPC-157 can be injected locally near the injury site for targeted effects or systemically (abdomen SubQ) for bodywide recovery. Local injection may provide faster results for specific injuries; systemic dosing covers everything.
BPC-157 research originated at the University of Zagreb under Professor Predrag Sikiric. Over 100 published studies demonstrate healing effects across tendons, ligaments, muscle, bone, gut, liver, brain, and peripheral nerves in animal models.
The gastric juice origin is significant — BPC-157 is inherently stable in gastric acid, which enables oral administration for GI-specific applications. This also explains its pronounced gut-protective effects and its ability to counteract NSAID-induced GI damage.
Despite the extensive preclinical data, formal human clinical trials remain limited. The peptide community's adoption has far outpaced the clinical research pipeline, making BPC-157 the most widely used research peptide worldwide. Anecdotal reports consistently align with the animal study findings.
| Compound | Target | Mechanism | Route | Research |
|---|---|---|---|---|
| BPC-157 | Multi-tissue | Growth Factors + NO | SubQ / Oral | 100+ studies |
| TB-500 | Systemic | Actin / Cell Migration | SubQ | Moderate |
| GHK-Cu | Skin / Collagen | 4000+ Gene Activation | SubQ / Topical | Extensive |
| LL-37 | Antimicrobial | Biofilm Disruption | SubQ | Moderate |
BPC-157's side effect profile is manageable with proper protocol adherence. Baseline blood work before starting and periodic monitoring during use is essential.
BPC-157 is the gateway peptide for a reason: it works across more tissue types than any other single compound, the safety profile is excellent, and the research base is extensive. Whether you're dealing with a tendon injury, gut issues, or post-surgical recovery, BPC-157 addresses the fundamental growth factor pathways that drive repair. The Wolverine Stack (BPC-157 + TB-500) is the most validated healing protocol in the peptide community. For GI-specific issues, the oral route provides direct mucosal contact. Inject locally for targeted injuries or systemically for bodywide coverage. Get imaging before and after for injuries to objectively track healing.
Our free Protocol Guide includes the complete Wolverine Stack — BPC-157 + TB-500 dosing, injection site guidance, and recovery tracking templates.